Home > Insider Trading > Filing (0001209191-21-002405)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1496323	Igm Biosciences Inc.	IGMS	Pharmaceutical Preparations (2834)	770349194

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1787362	Bruce Keyt	C/O Igm Biosciences, Inc. 325 E. Middlefield Road Mountain View CA 94043	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-01-04	883	$88.07	1,013	No	4	S	Indirect	See footnote
Common Stock	Acquisiton	2021-01-04	2,500	$0.93	5,269	No	4	M	Direct
Common Stock	Disposition	2021-01-04	997	$77.27	4,272	No	4	F	Direct
Common Stock	Disposition	2021-01-05	1,503	$79.33	2,769	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2021-01-04	2,500	$0.00	2,500	$0.93

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
25,264		2025-03-10	No	4	M	Direct

Footnotes

The sale was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person's spouse.
The shares are held directly by the reporting person's spouse.
The option exercise and sale were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
Represents shares withheld by the Issuer to pay the exercise price and taxes pursuant to the "net exercise" of 2,500 option shares.
The shares subject to the option are vested and exercisable as of the date hereof.